TY - JOUR
T1 - The pathophysiology and clinical presentation of cerebral amyloid angiopathy
AU - Auriel, Eitan
AU - Greenberg, Steven Mark
PY - 2012/8
Y1 - 2012/8
N2 - Cerebral amyloid angiopathy (CAA) is defined as the deposition of amyloid ß peptide within leptomeningial and cortical vessels, likely reflecting an imbalance between Aß production and clearance. Amyloid buildup triggers a series of destructive alterations in the cerebral vascular architecture, leading to a spectrum of neurological events including lobar intracerebral hemorrhage, brain ischemia and cognitive decline. Although traditionally diagnosed pathologically, neuroimaging has taken a central role in defining CAA. This review will discuss the pathological, clinical and radiological aspects of CAA.
AB - Cerebral amyloid angiopathy (CAA) is defined as the deposition of amyloid ß peptide within leptomeningial and cortical vessels, likely reflecting an imbalance between Aß production and clearance. Amyloid buildup triggers a series of destructive alterations in the cerebral vascular architecture, leading to a spectrum of neurological events including lobar intracerebral hemorrhage, brain ischemia and cognitive decline. Although traditionally diagnosed pathologically, neuroimaging has taken a central role in defining CAA. This review will discuss the pathological, clinical and radiological aspects of CAA.
KW - Cerebral amyloid angiopathy
KW - Intracerebral hemorrhage
KW - Stroke
KW - Vascular dementia
UR - http://www.scopus.com/inward/record.url?scp=84865592640&partnerID=8YFLogxK
U2 - 10.1007/s11883-012-0254-z
DO - 10.1007/s11883-012-0254-z
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22565298
AN - SCOPUS:84865592640
SN - 1523-3804
VL - 14
SP - 343
EP - 350
JO - Current Atherosclerosis Reports
JF - Current Atherosclerosis Reports
IS - 4
ER -